Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer: An Open-Label, Non-Comparative, Multicentre, Phase III Study by Lundström, Eija A., Rencken, Rupert K., van Wyk, Johann H., Coetzee, Lance J.E., Bahlmann, Johann C.M., Reif, Simon, Strasheim, Erdam A., Bigalke, Martin C., Pontin, Alan R., Goedhals, Louis, Steyn, Douw G., Heyns, Chris F., Aldera, Luigi A., Mackenzie, Thomas M., Purcea, Daniela, Grosgurin, Pierre Y., Porchet, Hervé C.

Get full text